Background, A high plasma homocysteine concentration is a risk factor for atherosclerosis and thrombosis, which are major causes of morbidity and mortality in heart transplant patients, High homocysteine concentrations may be caused by lower folate and vitamin B-6 levels, We hypothesized that these patients might have high homocysteine concentrations and low levels of folate and vitamin B-6, which could contribute to the development of vascular complications, Methods, Total fasting plasma homocysteine was measured in 189 cardiac transplant recipients and in healthy controls, as were concentrations of folate, vitamin B-12, vitamin B-6, and creatinine, Results, Homocysteine concentrations were higher in recipients than controls (19.1+/-13.0 vs, 11.0+/-3.0 mu mol/L, P<0.01), and hyperhomocysteinemia (>90th percentile for controls, 14.6 mu mol/L) was seen in 68% of recipients (P<0.01), Folate and vitamin B-6 concentrations were lower (5.9+/-4.2 vs. 7.9+/-4.2 pmol/L and 40+/-25 vs, 84+/-77 nmol/L, respectively; P<0.01 for both), Folate and vitamin B-6 deficiencies were seen in 10.8% and 17.9% of recipients, respectively (P<0.01), Hyperhomocysteinemia was more frequent in patients with vascular complications after transplantation than in those without (79.2% vs, 63.8%, P<0.05), Conclusions, Elevated plasma homocysteine and deficiencies of folate and vitamin B-6 are common in transplant recipients. A high homocysteine concentration was more common in patients with vascular complications, Prospective studies are now required to evaluate the role of these abnormalities as risk factors for the atherothrombotic complications of transplantation.